H.B. Fuller (FUL) shareholder Ancora said Tuesday it opposes the adhesives company's proposed acquisition of Advanced Medical Solutions "or any other material purchase."

In a letter sent to the company's board, Ancora urged a full review of strategic alternatives, including a potential sale of all or parts of the business, to maximize shareholder value.

The proposed acquisition would increase the company's leverage and introduce operating risks, the investment management firm said. It also appears to be a "poison pill" move intended to discourage meaningful acquirer interest, according to Ancora.

H.B. Fuller did not immediately reply to a request for comment from MT Newswires.

Price: 59.17, Change: +1.39, Percent Change: +2.41